RT Journal Article
SR Electronic
T1 Efficacy and Safety of Acupuncture for Acute Gouty Arthritis: A Systematic Review and Network Meta-Analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.21.24314132
DO 10.1101/2024.09.21.24314132
A1 Cai, Yuxiao
A1 Liu, Yifan
A1 Kang, Qinglong
A1 Zhu, Shiji
A1 Wang, Qianqian
A1 Sun, Chunmei
A1 Gu, Yin
YR 2024
UL http://medrxiv.org/content/early/2024/09/24/2024.09.21.24314132.abstract
AB Acute gouty arthritis (AGA) severely affects the quality of life of patients due to its persistent, recurrent, and debilitating characteristics. Acupuncture holds a pivotal role as a classical alternative therapy in managing gouty arthritis. This study aimed to assess the clinical effectiveness of various acupuncture methods used in conjunction with conventional medications for treating acute gouty arthritis. We conducted a search of seven English and Chinese databases up to February 10, 2024, and analyzed the data using R software version 4.4.0.The study included a total of 37 randomized controlled trials(RCT), encompassing 2,801 patients. The network meta-analysis (NMA) results are as follows: Fire acupuncture demonstrated the highest effectiveness in improving cure rates. Acupuncture combined with conventional medication was found to be the most effective for reducing VAS scores. Additionally, Acupuncture combined with conventional medication proved most effective in lowering uric acid levels. For reducing ESR, the combination of blood-letting therapy and conventional drugs showed the greatest efficacy. No statistically significant differences were found among the different interventions regarding the reduction of TCMSS and CRP levels. In conclusion, fire acupuncture showed the greatest overall effectiveness. Acupuncture with conventional medication best reduced VAS scores and uric acid levels, while blood-letting therapy combined with conventional drugs was most effective in lowering ESR.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesRegistration of Systematic Review: This study has been registered with PROSPERO under registration number CRD42021278233. Detailed information can be accessed at PROSPERO.